• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丹参酮IIA通过miR-497-5p/AKT3轴调节人急性髓系白血病细胞的增殖、细胞周期和凋亡。

Tanshinone IIA regulates human AML cell proliferation, cell cycle, and apoptosis through miR-497-5p/AKT3 axis.

作者信息

Nie Zi-Yuan, Zhao Ming-Hui, Cheng Bao-Qian, Pan Rong-Fang, Wang Tian-Rui, Qin Yan, Zhang Xue-Jun

机构信息

Department of Hematology, The Second Hospital of Hebei Medical University, Shijiazhuang, 050000 China.

Department of Radiology, Affiliated Hospital of Hebei University, Baoding, 071000 China.

出版信息

Cancer Cell Int. 2020 Aug 7;20:379. doi: 10.1186/s12935-020-01468-5. eCollection 2020.

DOI:10.1186/s12935-020-01468-5
PMID:32782437
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7412841/
Abstract

BACKGROUND

The roots of are used in traditional Chinese medicine (TCM) and have high medicinal value. Tanshinone IIA (Tan IIA) is the active ingredient of which can inhibit the growth of acute leukemia cell lines in vitro, although the mechanism remains unclear.

METHODS

CCK-8 assays and BrdU stain were used to evaluate cell proliferation ability. Western blot analysis was used to detect protein expression. miR-497-5p expression level was detected by using qRT-PCR, and Annexin V-FITC/propidium iodide (PI) was used to detect cell apoptosis.

RESULTS

Here we reported that Tan IIA could inhibit cell proliferation, induce cell cycle arrest, and promote cell apoptosis in acute myeloid leukemia (AML) cells. Thus, Tan IIA had the anti-cancer activity in AML cell lines, which was likely mediated by up-regulation of miR-497-5p expression. Our data further showed that in AML cells, the same effects were observed with overexpression of miR-497-5p by a miR-497-5p mimic. We demonstrated that Tan IIA could inhibit the expression of AKT3 by up-regulating the expression of miR-497-5p. We subsequently identified that AKT3 was the direct target of miR-497-5p, and that treatment with Tan IIA obviously reversed the effect of treatment with an miR-497-5p inhibitor under harsh conditions. In turn, PCNA expression was increased and cleaved Caspase-3 was suppressed, which contributed to the growth of AML cells.

CONCLUSIONS

Our results showed that Tan IIA could inhibit cell proliferation in AML cells through miR-497-5p-mediated AKT3 downregulation pathway.

摘要

背景

[某种植物]的根被用于传统中药,具有很高的药用价值。丹参酮IIA(Tan IIA)是[该植物]的活性成分,其在体外可抑制急性白血病细胞系的生长,尽管其机制尚不清楚。

方法

采用CCK-8法和BrdU染色评估细胞增殖能力。采用蛋白质印迹分析检测蛋白质表达。使用qRT-PCR检测miR-497-5p表达水平,并用膜联蛋白V-异硫氰酸荧光素/碘化丙啶(PI)检测细胞凋亡。

结果

在此我们报道Tan IIA可抑制急性髓系白血病(AML)细胞的增殖、诱导细胞周期停滞并促进细胞凋亡。因此,Tan IIA在AML细胞系中具有抗癌活性,这可能是通过上调miR-497-5p的表达介导的。我们的数据进一步表明,在AML细胞中,通过miR-497-5p模拟物过表达miR-497-5p也观察到了相同的效果。我们证明Tan IIA可通过上调miR-497-5p的表达来抑制AKT3的表达。随后我们确定AKT3是miR-497-5p的直接靶点,并且在苛刻条件下,Tan IIA处理明显逆转了miR-497-5p抑制剂处理的效果。反过来,增殖细胞核抗原(PCNA)表达增加,而裂解的半胱天冬酶-3受到抑制,这促进了AML细胞的生长。

结论

我们的结果表明,Tan IIA可通过miR-497-5p介导的AKT3下调途径抑制AML细胞的增殖。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2df/7412841/096b8937376e/12935_2020_1468_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2df/7412841/83691f72d083/12935_2020_1468_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2df/7412841/abbb4662518b/12935_2020_1468_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2df/7412841/592995fddfbc/12935_2020_1468_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2df/7412841/83f60639f145/12935_2020_1468_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2df/7412841/096b8937376e/12935_2020_1468_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2df/7412841/83691f72d083/12935_2020_1468_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2df/7412841/abbb4662518b/12935_2020_1468_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2df/7412841/592995fddfbc/12935_2020_1468_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2df/7412841/83f60639f145/12935_2020_1468_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2df/7412841/096b8937376e/12935_2020_1468_Fig5_HTML.jpg

相似文献

1
Tanshinone IIA regulates human AML cell proliferation, cell cycle, and apoptosis through miR-497-5p/AKT3 axis.丹参酮IIA通过miR-497-5p/AKT3轴调节人急性髓系白血病细胞的增殖、细胞周期和凋亡。
Cancer Cell Int. 2020 Aug 7;20:379. doi: 10.1186/s12935-020-01468-5. eCollection 2020.
2
Tanshinone IIA induces apoptosis and autophagy in acute monocytic leukemia via downregulation of PI3K/Akt pathway.丹参酮IIA通过下调PI3K/Akt通路诱导急性单核细胞白血病细胞凋亡和自噬。
Am J Transl Res. 2019 May 15;11(5):2995-3006. eCollection 2019.
3
Tanshinone IIA Ameliorates Progression of CAD Through Regulating Cardiac H9c2 Cells Proliferation and Apoptosis by miR-133a-3p/EGFR Axis.丹参酮IIA通过miR-133a-3p/EGFR轴调节心肌H9c2细胞增殖和凋亡改善冠状动脉疾病进展
Drug Des Devel Ther. 2020 Jul 20;14:2853-2863. doi: 10.2147/DDDT.S245970. eCollection 2020.
4
CircMYC regulates the mitochondrial respiration and cell viability miR-516a-5p/AKT3 axis in acute myeloid leukemia.环状MYC通过miR-516a-5p/AKT3轴调节急性髓系白血病中的线粒体呼吸和细胞活力。
Am J Transl Res. 2021 Sep 15;13(9):10112-10126. eCollection 2021.
5
Tanshinone IIA Regulates MAPK/mTOR Signal-Mediated Autophagy to Alleviate Atherosclerosis through the miR-214-3p/ATG16L1 Axis.丹参酮 IIA 通过 miR-214-3p/ATG16L1 轴调控 MAPK/mTOR 信号通路介导的自噬缓解动脉粥样硬化。
Int Heart J. 2023;64(5):945-954. doi: 10.1536/ihj.23-087.
6
Tanshinone IIA reverses oxaliplatin resistance in colorectal cancer through microRNA-30b-5p/AVEN axis.丹参酮IIA通过微小RNA-30b-5p/凋亡抑制因子轴逆转结直肠癌对奥沙利铂的耐药性。
Open Med (Wars). 2022 Jul 12;17(1):1228-1240. doi: 10.1515/med-2022-0512. eCollection 2022.
7
Analysis of tanshinone IIA induced cellular apoptosis in leukemia cells by genome-wide expression profiling.通过全基因组表达谱分析丹参酮 IIA 诱导白血病细胞凋亡。
BMC Complement Altern Med. 2012 Jan 16;12:5. doi: 10.1186/1472-6882-12-5.
8
Upregulation of miR-582-5p regulates cell proliferation and apoptosis by targeting AKT3 in human endometrial carcinoma.miR-582-5p的上调通过靶向人子宫内膜癌中的AKT3来调节细胞增殖和凋亡。
Saudi J Biol Sci. 2018 Jul;25(5):965-970. doi: 10.1016/j.sjbs.2018.03.007. Epub 2018 Mar 10.
9
Tanshinone IIA attenuates high glucose induced human VSMC proliferation and migration through miR-21-5p-mediated tropomyosin 1 downregulation.丹参酮 IIA 通过 miR-21-5p 介导的原肌球蛋白 1 下调抑制高糖诱导的人血管平滑肌细胞增殖和迁移。
Arch Biochem Biophys. 2019 Nov 30;677:108154. doi: 10.1016/j.abb.2019.108154. Epub 2019 Oct 28.
10
Human mesenchymal stem cells derived exosomes inhibit the growth of acute myeloid leukemia cells via regulating miR-23b-5p/TRIM14 pathway.人骨髓间充质干细胞来源的外泌体通过调控 miR-23b-5p/TRIM14 通路抑制急性髓系白血病细胞的生长。
Mol Med. 2021 Oct 16;27(1):128. doi: 10.1186/s10020-021-00393-1.

引用本文的文献

1
Derivation of a novel multi-gene prognostic model based on regulated cell death pathways in acute myeloid leukemia: A comprehensive bioinformatic analysis integrating gene expression, mutation profiling, and immune infiltration.基于急性髓系白血病调控性细胞死亡途径的新型多基因预后模型的推导:整合基因表达、突变谱分析和免疫浸润的综合生物信息学分析
PLoS One. 2025 Aug 1;20(8):e0328412. doi: 10.1371/journal.pone.0328412. eCollection 2025.
2
Tanshinone IIA induces ferroptosis in colorectal cancer cells through the suppression of SLC7A11 expression via the PI3K/AKT/mTOR pathway.丹参酮IIA通过PI3K/AKT/mTOR途径抑制SLC7A11表达,从而诱导大肠癌细胞发生铁死亡。
Eur J Med Res. 2025 Jul 5;30(1):576. doi: 10.1186/s40001-025-02842-7.
3

本文引用的文献

1
MiR-9 functions as a tumor suppressor in acute myeloid leukemia by targeting CX chemokine receptor 4.微小RNA-9通过靶向CXC趋化因子受体4在急性髓系白血病中发挥肿瘤抑制作用。
Am J Transl Res. 2019 Jun 15;11(6):3384-3397. eCollection 2019.
2
Tanshinone IIA induces apoptosis and autophagy in acute monocytic leukemia via downregulation of PI3K/Akt pathway.丹参酮IIA通过下调PI3K/Akt通路诱导急性单核细胞白血病细胞凋亡和自噬。
Am J Transl Res. 2019 May 15;11(5):2995-3006. eCollection 2019.
3
MicroRNA-497-5p inhibits proliferation and invasion of non-small cell lung cancer by regulating FGF2.
Tanshinone II A Facilitates Chemosensitivity of Osteosarcoma Cells to Cisplatin via Activation of p38 MAPK Pathway.
丹参酮IIA通过激活p38丝裂原活化蛋白激酶途径促进骨肉瘤细胞对顺铂的化疗敏感性。
Chin J Integr Med. 2025 Apr;31(4):326-335. doi: 10.1007/s11655-024-4118-5. Epub 2024 Nov 5.
4
Anti-CLL1 liposome loaded with miR-497-5p and venetoclax as a novel therapeutic strategy in acute myeloid leukemia.载有 miR-497-5p 和 venetoclax 的抗 CLL1 脂质体作为急性髓系白血病的一种新的治疗策略。
Mol Ther. 2024 Nov 6;32(11):4058-4074. doi: 10.1016/j.ymthe.2024.09.036. Epub 2024 Oct 5.
5
Traditional Chinese medicine for acute myelocytic leukemia therapy: exploiting epigenetic targets.用于急性髓细胞白血病治疗的中药:靶向表观遗传靶点
Front Pharmacol. 2024 Jun 4;15:1388903. doi: 10.3389/fphar.2024.1388903. eCollection 2024.
6
The mechanisms of tanshinone in the treatment of tumors.丹参酮治疗肿瘤的机制。
Front Pharmacol. 2023 Oct 26;14:1282203. doi: 10.3389/fphar.2023.1282203. eCollection 2023.
7
Tanshinone IIA targeting cell signaling pathways: a plausible paradigm for cancer therapy.丹参酮 IIA 靶向细胞信号通路:癌症治疗的合理范例。
Pharmacol Rep. 2023 Aug;75(4):907-922. doi: 10.1007/s43440-023-00507-y. Epub 2023 Jul 13.
8
Multifaceted Pharmacological Potentials of Curcumin, Genistein, and Tanshinone IIA through Proteomic Approaches: An In-Depth Review.通过蛋白质组学方法探究姜黄素、染料木黄酮和丹参酮IIA的多方面药理潜力:深入综述
Cancers (Basel). 2022 Dec 30;15(1):249. doi: 10.3390/cancers15010249.
9
A cellular regulator of the niche: telocyte.龛的细胞调节子:telocyte。
Tissue Barriers. 2023 Oct 2;11(4):2131955. doi: 10.1080/21688370.2022.2131955. Epub 2022 Oct 11.
10
in cancer: Potential role in regulating MicroRNAs and epigenetic enzymes.在癌症中:在调节微小RNA和表观遗传酶方面的潜在作用。
Front Pharmacol. 2022 Sep 12;13:1008222. doi: 10.3389/fphar.2022.1008222. eCollection 2022.
微小RNA-497-5p通过调控成纤维细胞生长因子2抑制非小细胞肺癌的增殖和侵袭。
Oncol Lett. 2019 Mar;17(3):3425-3431. doi: 10.3892/ol.2019.9954. Epub 2019 Jan 21.
4
miR-497-5p inhibits tumor cell growth and invasion by targeting SOX5 in non-small-cell lung cancer.miR-497-5p通过靶向SOX5抑制非小细胞肺癌中的肿瘤细胞生长和侵袭。
J Cell Biochem. 2019 Jun;120(6):10587-10595. doi: 10.1002/jcb.28345. Epub 2019 Feb 28.
5
miR-345-5p regulates proliferation, cell cycle, and apoptosis of acute myeloid leukemia cells by targeting AKT2.微小RNA-345-5p通过靶向AKT2调控急性髓系白血病细胞的增殖、细胞周期和凋亡。
J Cell Biochem. 2019 Feb;120(2):1620-1629. doi: 10.1002/jcb.27461. Epub 2018 Oct 2.
6
Overexpression of miR‑21 is involved in acute monocytic leukemia‑associated angiogenesis by targeting IL‑12.miR-21 的过表达通过靶向 IL-12 参与急性单核细胞白血病相关的血管生成。
Mol Med Rep. 2018 Oct;18(4):4122-4128. doi: 10.3892/mmr.2018.9357. Epub 2018 Aug 6.
7
Identification of serum miR-34a as a potential biomarker in acute myeloid leukemia.血清 miR-34a 作为急性髓系白血病潜在生物标志物的鉴定。
Cancer Biomark. 2018;22(4):799-805. doi: 10.3233/CBM-181381.
8
MicroRNA-126 attenuates cell apoptosis by targeting TRAF7 in acute myeloid leukemia cells.MicroRNA-126 通过靶向 TRAF7 减轻急性髓系白血病细胞凋亡。
Biochem Cell Biol. 2018 Dec;96(6):840-846. doi: 10.1139/bcb-2018-0017.
9
MiR-204 acts as a potential therapeutic target in acute myeloid leukemia by increasing BIRC6-mediated apoptosis.miR-204 通过增加 BIRC6 介导的细胞凋亡在急性髓系白血病中作为潜在的治疗靶点。
BMB Rep. 2018 Sep;51(9):444-449. doi: 10.5483/bmbrep.2018.51.9.036.
10
MiR-497-5p, miR-195-5p and miR-455-3p function as tumor suppressors by targeting hTERT in melanoma A375 cells.MiR-497-5p、miR-195-5p和miR-455-3p通过靶向黑素瘤A375细胞中的hTERT发挥肿瘤抑制作用。
Cancer Manag Res. 2018 May 3;10:989-1003. doi: 10.2147/CMAR.S163335. eCollection 2018.